Accelerating Biomarker Discovery Through Electronic Health Records, Automated Biobanking, and Proteomics
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Background: Circulating biomarkers can facilitate diagnosis and risk stratification for complex conditions such as heart failure (HF). Newer molecular platforms can accelerate biomarker discovery, but they require significant resources for data and sample acquisition. Objectives: To test a pragmatic biomarker discovery strategy integrating automated clinical biobanking with proteomics. Methods: Using the EHR, we identified patients with and without HF, retrieved their discarded plasma samples, and screened these specimens using a DNA aptamer-based proteomic platform (1,129 proteins). Candidate biomarkers were validated in three different prospective cohorts. Results: In an automated manner, plasma samples from 1,315 patients (31% with HF) were collected. Proteomic analysis of a 96-patient subset identified nine candidate biomarkers (p <4.42 × 10−5). Two proteins, angiopoietin-2 and thrombospondin-2, were associated with HF in three separate validation cohorts. In an emergency department-based registry of 852 dyspneic patients, the 2 biomarkers improved discrimination of acute HF compared with a clinical score (p <0.0001) or clinical score plus B-type natriuretic peptide (p=0.02). In a community-based cohort (n = 768), both biomarkers predicted incident HF independent of traditional risk factors and NTproBNP (HR per SD increment, 1.35 [95%CI, 1.14 to 1.61, p = 0.0007] for angiopoietin-2, and 1.37 [1.06–1.79, p = 0.02] for thrombospondin-2). Among 30 advanced HF patients, concentrations of both biomarkers declined (80–84%) following cardiac transplant (p <0.001 for both). Conclusions: A novel strategy integrating EHRs, discarded clinical specimens, and proteomics identified two biomarkers that robustly predict HF across diverse clinical settings. This approach could accelerate biomarker discovery for many diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery
Gold, L., Ayers, D., Bertino, J., Bock, C., Bock, A., Brody, E. N., Carter, J., Dalby, A. B., Eaton, B. E., Fitzwater, T., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015004 · Cited by 1,754 · cited 3×
“Antiplatelet med 651 (50) 301 (73) 292 (51) 58 (18)”
MethodAngiopoietin-2 Is Critical for Cytokine-Induced Vascular Leakage
Benest, A. V., Kruse, K., Savant, S., Thomas, M., Laib, A. M., Loos, E. K., Fiedler, U., & Augustin, H. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070459 · Cited by 178 · cited 1×
“Angiopoietin-2 is an endothelial cell-derived factor linked to the regulation of vascular permeability (31,32).”
BackgroundVan Driest, S. L., Wells, Q. S., Stallings, S., Bush, W. S., Gordon, A., Nickerson, D. A., Kim, J. H., Crosslin, D. R., Jarvik, G. P., Carrell, D. S., et al. (2016) · JAMA · doi:10.1001/jama.2015.17701 · Cited by 170
Self-citation
Cited by
Khan, S. S., Coresh, J., Pencina, M. J., Ndumele, C. E., Rangaswami, J., Chow, S. L., Palaniappan, L. P., Sperling, L. S., Virani, S. S., Ho, J. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001191 · Cited by 797
Enabling Technologies for Personalized and Precision Medicine
Ho, D., Quake, S. R., McCabe, E. R. B., Chng, W. J., Chow, E. K., Ding, X., Gelb, B. D., Ginsburg, G. S., Hassenstab, J., Ho, C.-M., et al. (2020) · Trends in Biotechnology · doi:10.1016/j.tibtech.2019.12.021 · Cited by 517
How Will Genetics Inform the Clinical Care of Atrial Fibrillation?
Shoemaker, M. B., Shah, R. L., Roden, D. M., & Perez, M. V. (2020) · Circulation Research · doi:10.1161/circresaha.120.316365 · Cited by 27
Self-citationOpportunities and challenges for biomarker discovery using electronic health record data
Singhal, P., Tan, A. L. M., Drivas, T. G., Johnson, K. B., Ritchie, M. D., & Beaulieu-Jones, B. K. (2023) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.06.006 · Cited by 21
Metadata
- Authors
- Wells, Q. S., Gupta, D. K., Smith, J. G., Collins, S. P., Storrow, A. B., Ferguson, J., Smith, M. L., Pulley, J. M., Collier, S., Wang, X., Roden, D. M., Gerszten, R. E., & Wang, T. J.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2019-05
- Volume
- 73
- Issue
- 17
- Pages
- 2195-2205
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2942868820
- Cited by
- 51
- References
- 3
- FWCI
- 4.24
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.